Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report

Since December 2019, the outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly around the world. The severity of COVID-19 ranges from asymptomatic carriers to severe acute respiratory distress syndrome (ARDS). Accumulating evidence has shown that COVID-19 may be associated with multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao-Yu, Pan, Chien-Ting, Cheng, Chiao-Feng, Lin, Chi-Ying, Chang, Sheng-Nan, Chen, Yi-Chung, Wang, Chih-Yuan, Chen, Yen-Fu, Chen, Chung-Yu, Ma, Matthew Huei-Ming, Hwang, Juey-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988442/
https://www.ncbi.nlm.nih.gov/pubmed/33838985
http://dx.doi.org/10.1016/j.jfma.2021.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988442/
https://www.ncbi.nlm.nih.gov/pubmed/33838985
http://dx.doi.org/10.1016/j.jfma.2021.03.014

Ejemplares similares